Jim Cramer breaks down shares of Meta, Nvidia, Apple and more

Jim Cramer breaks down shares of Meta, Nvidia, Apple and more

CNBC’s Jim Cramer and the ‘Squawk on the Street’ team break down shares of Meta, Apple, Nvidia and more following a slew of earnings report from Big Tech companies.

Read More »
Plexo Capital's Lo Toney breaks down key takeaways from Big Tech earnings

Plexo Capital’s Lo Toney breaks down key takeaways from Big Tech earnings

Lo Toney, founder and managing partner at Plexo Capital, joins CNBC’s ‘Squawk Box’ to provide an earnings outlook for Apple and Amazon.

Read More »
Jim Cramer explains why shares of ServiceNow are a buy

Jim Cramer explains why shares of ServiceNow are a buy

‘Mad Money’ host Jim Cramer breaks down shares of cloud computing company ServiceNow following its first-quarter earnings results.

Read More »
Fed Chair Jay Powell can navigate a soft landing, says Jim Cramer

Fed Chair Jay Powell can navigate a soft landing, says Jim Cramer

‘Mad Money’ host Jim Cramer joins ‘Squawk Box’ to break down markets ahead of the open.

Read More »
U.S. GDP makes surprising 1.4% drop during first quarter

U.S. GDP makes surprising 1.4% drop during first quarter

CNBC’s Rick Santelli joins ‘Squawk Box’ to break down the initial first-quarter U.S. GDP and weekly jobless claims data.

Read More »
Elon Musk faces backlash after targeting Twitter lawyer: Report

Elon Musk faces backlash after targeting Twitter lawyer: Report

Alan Guarino, Korn Ferry vice chairman, Tsedal Neeley, Harvard Business School professor, and CNBC’s Jon Fortt joins CNBC’s ‘Squawk Box’ to discuss Elon Musk’s recent tweet criticizing Twitter’s top lawyer.

Read More »
Ford CFO John Lawler: We are not seeing any signs of easing demand

Ford CFO John Lawler: We are not seeing any signs of easing demand

CNBC’s Phil LeBeau sits down with Ford CFO John Lawler to break down the company’s first-quarter earnings results and the company’s expectations for the second quarter.

Read More »
Eli Lilly CEO David Ricks breaks down Q1 earnings, obesity drug trial results

Eli Lilly CEO David Ricks breaks down Q1 earnings, obesity drug trial results

Eli Lilly CEO David Ricks joins CNBC’s Meg Tirrell and the ‘Squawk Box’ team to break down the company’s latest earnings report and its clinical trial results for weight-loss drug tirzepatide.

Read More »